Yoga for Treating People at Risk for Diabetes or With Both HIV and Depression
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00090506|
Recruitment Status : Completed
First Posted : August 27, 2004
Last Update Posted : January 25, 2008
|Condition or disease||Intervention/treatment||Phase|
|HIV Infections Diabetes Depression||Behavioral: Yoga||Phase 1|
In recent years, western health practitioners have become increasingly aware of the potential health benefits of yoga. This study will comprise two substudies that will evaluate the effects of yoga in two distinct populations.
Participants in the first study will be people who are at risk for developing diabetes; participants in the second study will be people with both HIV and depression. All participants will practice yoga 3 to 6 days per week for 3 months. Blood collection will be done and weight and blood pressure measurements will be taken in study 1 participants; questionnaires will be used to measure depression and stress in study 2 participants. All study participants will be assessed at entry and at 3 and 6 months.
|Study Type :||Interventional (Clinical Trial)|
|Enrollment :||50 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Yoga, Health, and Meditation|
|Study Start Date :||July 2004|
|Actual Primary Completion Date :||March 2007|
|Actual Study Completion Date :||March 2007|
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00090506
|Swami Vivekananda Yoga Anusandhana Samsthana (SVAYSA)|
|Principal Investigator:||Frederick M. Hecht, MD||UCSF Positive Health Program|